Divided Federal Circuit Affirms: Schizophrenia Treatment Patent Infringed

Mealey's (April 16, 2018, 1:45 PM EDT) -- WASHINGTON, D.C. — In an April 13 holding, the Federal Circuit U.S. Court of Appeals upheld a Delaware federal judge’s determination that a patented method of treating schizophrenia patients with iloperidone,...
To view the full article, register now.